These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16790126)

  • 1. Screening for prostate cancer.
    Malone P
    Ann R Coll Surg Engl; 2005 Mar; 87(2):88-9. PubMed ID: 16790126
    [No Abstract]   [Full Text] [Related]  

  • 2. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's new in prostate cancer screening and prevention?
    Klein EA
    Cleve Clin J Med; 2009 Aug; 76(8):439-45. PubMed ID: 19652036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening.
    Catalona WJ
    BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of prostate-specific antigen in prostate cancer.
    Liang SL
    MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
    Hayes JH; Barry MJ; Kantoff PW; Stahl JE
    BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen and prostate cancer prognosis.
    Church TR
    J Natl Cancer Inst; 2006 Nov; 98(21):1509-10. PubMed ID: 17077347
    [No Abstract]   [Full Text] [Related]  

  • 8. Is a screening interval of every 4 years for prostate cancer acceptable?
    Crawford ED
    J Natl Cancer Inst; 2007 Sep; 99(17):1279-80. PubMed ID: 17728212
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversies regarding screening for prostate cancer.
    Crawford ED; Thompson IM
    BJU Int; 2007 Jul; 100 Suppl 2():5-7. PubMed ID: 17594348
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
    Roobol MJ; Schröder FH
    J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
    Hamilton RJ; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer: current evidence weighs against population screening.
    Boyle P; Brawley OW
    CA Cancer J Clin; 2009; 59(4):220-4. PubMed ID: 19564244
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for prostate cancer: a public campaign, evidence-based-medicine and conflicting interests.
    Braillon A; Dubois G; Zielinski O
    Eur J Public Health; 2009 Apr; 19(2):222. PubMed ID: 19001462
    [No Abstract]   [Full Text] [Related]  

  • 14. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 15. The jury is still out with regard to screening for the prostate cancer with prostate-specific antigen.
    Eur J Cancer Care (Engl); 2002 Jun; 11(2):78. PubMed ID: 12168606
    [No Abstract]   [Full Text] [Related]  

  • 16. PSA and prostate cancer screening: the challenge of the new millennium.
    Bjartell A
    Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer: screening and early detection.
    Tariman JD
    Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
    [No Abstract]   [Full Text] [Related]  

  • 18. Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer.
    Boscolo-Berto R
    Int J Urol; 2009 Sep; 16(9):711. PubMed ID: 19769655
    [No Abstract]   [Full Text] [Related]  

  • 19. Who's too old to test?
    Springen K
    Newsweek; 2008 Aug 18-25; 152(7-8):64. PubMed ID: 18763326
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate specific antigen screening and active surveillance in the elderly.
    Konety BR
    J Urol; 2009 Apr; 181(4):1534-5. PubMed ID: 19230925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.